Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer

This publication has 14 references indexed in Scilit:

• Clinical Significance of a Multiple Biomarker Assay in Patients with Lung Cancer
  Chest, 1990
• Clinical Significance of the Number of Positive Tumor Markers in Assisting the Diagnosis of Lung Cancer with Multiple Tumor Marker Assay
  Oncology, 1990
• A clinical evaluation of the versality of various tumor markers in diagnosing the primary carcinoma of the lung
  Nihon Ika Daigaku Zasshi, 1989
• Serum levels of CA-50, CA-19.9, CA-125, neuron specific enolase and carcinoembryonic antigen in lung cancer and benign diseases of the lung
  Biomedicine & Pharmacotherapy, 1989
• Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancer
  Cancer, 1988
• Multiple Markers for Lung Cancer Diagnosis: Validation of Models for Localized Lung Cancer
  JNCI Journal of the National Cancer Institute, 1988
• Neuron-specific enolase (NSE): A useful marker in small cell lung cancer
  Lung Cancer, 1987
• Performance of Screening and Diagnostic Tests
  Archives of General Psychiatry, 1987
• Staging of lung cancer: The new international system
  Lung Cancer, 1987
• Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma.
  BMJ, 1984